Palmitoylethanolamide (PEA)
| 製品名 | Palmitoylethanolamide (PEA) |
|---|---|
| CAS番号 | 544-31-0 |
| 別名 | N-(2-Hydroxyethyl)hexadecanamide, PEA, Palmidrol |
| 分子式 | C18H37NO2 |
| 分子量 | 299.49 g/mol |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98.0% |
| 融点 | 98-102°C |
| 溶解度 | Soluble in ethanol, DMSO, dimethylformamide; practically insoluble in water |
| 乾燥減量 | ≤0.5% |
| 重金属 | 10 ppm以下 |
| パッケージ | 25 kg fiber drum with double polyethylene liner |
お困りですか? 弊社チームまでお問い合わせください

同義語: Palmitoylethanolamide, PEA, N-(2-Hydroxyethyl)hexadecanamide, Palmidrol, N-Hexadecanoylethanolamine, Hydroxyethylpalmitamide, Impulsin
Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide belonging to the class of nuclear factor agonists. It is synthesized endogenously in humans and animals, and is also found in various plant sources such as egg yolk, peanuts, and soybeans. For commercial and research applications, PEA is typically produced through chemical synthesis or enzymatic routes, yielding a high-purity white crystalline powder. Our PEA is manufactured under strict quality control and is available with a minimum assay of 98% as determined by HPLC.
As a specialized supplier, LyvBio provides PEA in bulk quantities to pharmaceutical, nutraceutical, and research organizations worldwide. Its unique mechanism of action, involving the modulation of peroxisome proliferator-activated receptor alpha (PPAR-α) and cannabinoid-like receptors, has attracted significant interest for its potential in managing neuropathic pain, inflammation, and related conditions. This product is intended for further processing or research purposes only, not for direct human consumption.
| パラメータ | 仕様 |
|---|---|
| 分析(HPLC) | ≥98.0% |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 識別 | IR and NMR spectra conform to structure |
| 乾燥減量 | ≤0.5% |
| 重金属 | 10 ppm以下 |
| 残留溶剤 | Meets USP requirements |